Q-201 (QUE Oncology)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameQ-201 (QUE Oncology)
Drug Alias Nameneuropathic cancer pain program (QUE Oncology/University of Queensland)Q-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCancer PainNeuralgiaPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of QueenslandQue Oncology Inc
Active IndicationsN/A
Inactive IndicationsCancer PainNeuralgiaPeripheral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A